Evogene (TASE:EVGN) (NASDAQ:EVGN) is a pioneering firm dedicated to leveraging computational biology to accelerate the development of products in the life sciences field. The company's operations span across multiple sectors, including agriculture, human health, and industrial applications, with projects focused on improving crop yields, developing effective therapeutics, and finding efficient bio-based solutions to conventional chemical processes. With an advanced computational platform, Evogene aims to discover and harness the vast potential of the biological world, addressing some of the most pressing issues faced by humanity, such as food security, disease, and environmental sustainability. Through its diverse and innovative projects, Evogene strives to achieve its objectives of creating sustainable solutions that benefit both the planet and its inhabitants.